Evidence map›Paper›PMID 33248443›Full record

ArticleEndocrinology2021

MicroRNA-7a2 Regulates Prolactin in Developing Lactotrophs and Prolactinoma Cells.

Mary P LaPierre, Svenja Godbersen, Mònica Torres Esteban, Anaïs Nura Schad, Mathias Treier, Umesh Ghoshdastider, Markus Stoffel

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. MiR-7 in Cancer Development.Biomedicines · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mary P LaPierreInstitute of Molecular Health Sciences, ETH Zürich, Zürich, Switzerland.
Svenja GodbersenInstitute of Molecular Health Sciences, ETH Zürich, Zürich, Switzerland.
Mònica Torres EstebanInstitute of Molecular Health Sciences, ETH Zürich, Zürich, Switzerland.
Anaïs Nura SchadInstitute of Molecular Health Sciences, ETH Zürich, Zürich, Switzerland.
Mathias TreierMax Delbrück Zentrum für molekulare Medizin (MDC), Berlin, Germany.
Umesh GhoshdastiderInstitute of Molecular Health Sciences, ETH Zürich, Zürich, Switzerland.
Markus StoffelInstitute of Molecular Health Sciences, ETH Zürich, Zürich, Switzerland.
ETH Zurich · CHMax Delbrück Center · DEUniversity of Zurich · CH

Funding

CIHR DFS – 152262
6 · The paper itself

Abstract

Prolactin production is controlled by a complex and temporally dynamic network of factors. Despite this tightly coordinated system, pathological hyperprolactinemia is a common endocrine disorder that is often not understood, thereby highlighting the need to expand our molecular understanding of lactotroph cell regulation. MicroRNA-7 (miR-7) is the most highly expressed miRNA family in the pituitary gland and the loss of the miR-7 family member, miR-7a2, is sufficient to reduce prolactin gene expression in mice. Here, we used conditional loss-of-function and gain-of-function mouse models to characterize the function of miR-7a2 in lactotroph cells. We found that pituitary miR-7a2 expression undergoes developmental and sex hormone-dependent regulation. Unexpectedly, the loss of mir-7a2 induces a premature increase in prolactin expression and lactotroph abundance during embryonic development, followed by a gradual loss of prolactin into adulthood. On the other hand, lactotroph development is delayed in mice overexpressing miR-7a2. This regulation of lactotroph function by miR-7a2 involves complementary mechanisms in multiple cell populations. In mouse pituitary and rat prolactinoma cells, miR-7a2 represses its target Raf1, which promotes prolactin gene expression. These findings shed light on the complex regulation of prolactin production and may have implications for the physiological and pathological mechanisms underlying hyperprolactinemia.

Indexed as

AnimalsCell LineEstradiolFemaleFertilityLactationLactotrophsMaleMiceMicroRNAsPituitary NeoplasmsProlactinProlactinomaProto-Oncogene Proteins c-rafSex CharacteristicsEstradiolMicroRNAsMIRN7 microRNA, mouseProlactinProto-Oncogene Proteins c-rafRaf1 protein, mousedevelopmentlactotrophmicroRNA-7a2pituitaryprolactinRaf1

Identifiers

PMID33248443
PMCPMC7774778
OpenAlexW3110482511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.